California SB 950 requires health plans to cover FDA-approved Alzhe…

The Frame

What this does

This change ensures that patients with Alzheimer's and memory disorders can access FDA-approved treatments immediately upon provider recommendation, removing insurance-imposed delays or requirements to fail on other medications first.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Patients with Alzheimer's disease

Patients gain access to FDA-approved treatments without the requirement to undergo step therapy protocols.

Health care service plans

Plans must update coverage policies to include all FDA-approved Alzheimer's treatments and remove step therapy requirements.

What changed

Last recorded activity August 30, 2026.

What's next

Introduced.

Summary

Starting January 1, 2027, health insurance plans in California must cover all FDA-approved medications and treatments for Alzheimer's disease and memory-related conditions when deemed medically necessary by a provider. The bill also prohibits insurers from requiring ''—a process where patients must try cheaper drugs first—before authorizing these treatments.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This change ensures that patients with Alzheimer's and memory disorders can access FDA-approved treatments immediately upon provider recommendation, removing insurance-imposed delays or requirements to fail on other medications first.

Frequently Asked Questions

Does this bill apply to all health insurance plans?

It applies to health care service plan contracts and disability insurance policies issued, amended, or renewed on or after January 1, 2027.

What is 'step therapy' and why is it being prohibited?

is a protocol where insurers require patients to try cheaper or different drugs before approving a specific treatment; this bill prohibits that practice for FDA-approved Alzheimer's and memory-related treatments.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Elimination of Step Therapy for Alzheimer's

The bill represents a targeted legislative effort to remove cost-containment barriers (step therapy) specifically for Alzheimer's and memory-related treatments.

Alzheimer's disease

Connected Entities

organizationDepartment of Managed Health Care“Regulates health care service plans under the Knox-Keene Act.”Map →

organizationUnited States Food and Drug Administration“Approves the treatments and medications that must be covered under this bill.”Map →

otherKnox-Keene Health Care Service Plan Act of 1975“Existing law governing health care service plans.”Map →

organizationDepartment of Insurance“Regulates health insurers.”Map →

Sources

Open source document

openstates.org

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz30
Current news / social attention level

California SB 950 requires health plans to cover FDA-approved Alzheimer's treatments without step therapy